Alfuzosin in pharma franchise in Maharashtra

Alfuzosin in PCD pharma franchise in Kohima

Alfuzosin in top pharma company in Howrah

Alfuzosin in pcd pharma supplier in Kochi

Alfuzosin In phama franchise company in India
Alfuzosin in phama distributor in Patiala

Home/Products /alfuzosin-10mg-tablet

Alfuxyle 10 Tablet

Composition : Alfuzosin (10mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹199/-

Alfuxyle 10 Tablet is a specialized medication for the effective management of benign prostatic hyperplasia (BPH), a condition commonly seen in aging men. It belongs to the alpha-adrenergic blocker class, which works by relaxing the muscles in the prostate and bladder neck. This action helps to improve urine flow, alleviate symptoms like difficulty in starting urination, incomplete bladder emptying, and frequent urination, especially at night.

By targeting the smooth muscle receptors in the urinary tract, Alfuzosin significantly enhances the quality of life in patients with moderate to severe urinary symptoms due to BPH. This treatment does not reduce the size of the prostate but focuses on providing symptomatic relief. Regular use as prescribed by a healthcare professional ensures consistent benefits, often visible within a few days of starting therapy.

Alfuxyle 10 Tablet is easy to incorporate into a daily routine, offering convenience alongside therapeutic benefits. Patients are advised to take it after meals to reduce the risk of dizziness or lightheadedness. Regular medical check-ups are recommended during the course of treatment to monitor progress and ensure optimal outcomes.

Read More

About the Product

Alfuxyle 10 Tablet is a specialized medication for the effective management of benign prostatic hyperplasia (BPH), a condition commonly seen in aging men. It belongs to the alpha-adrenergic blocker class, which works by relaxing the muscles in the prostate and bladder neck. This action helps to improve urine flow, alleviate symptoms like difficulty in starting urination, incomplete bladder emptying, and frequent urination, especially at night.

By targeting the smooth muscle receptors in the urinary tract, Alfuzosin significantly enhances the quality of life in patients with moderate to severe urinary symptoms due to BPH. This treatment does not reduce the size of the prostate but focuses on providing symptomatic relief. Regular use as prescribed by a healthcare professional ensures consistent benefits, often visible within a few days of starting therapy.

Alfuxyle 10 Tablet is easy to incorporate into a daily routine, offering convenience alongside therapeutic benefits. Patients are advised to take it after meals to reduce the risk of dizziness or lightheadedness. Regular medical check-ups are recommended during the course of treatment to monitor progress and ensure optimal outcomes.

Common side effects include dizziness, headache, fatigue, or nausea. Rarely, it may cause low blood pressure or fainting.

Used for the treatment of benign prostatic hyperplasia (BPH) to improve urinary flow and relieve associated symptoms.

Not intended for use in women or children. Avoid activities requiring alertness, such as driving, if dizziness occurs. Consult a doctor if symptoms persist or worsen.

Store in a cool, dry place at room temperature. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation